Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic Adoptive Immune Therapy for Advanced AIDS
NCT04098770Phase 2Unknown
- Sponsor
- The Fifth Medical Center of the PLA General Hospital
- Start
- Oct 2019
- Primary completion
- Dec 2023
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of Allogeneic Adoptive Immune Therapy in acquired immunodeficiency syndrome (AIDS), sponsored by The Fifth Medical Center of the PLA General Hospital. Status: unknown.
02
Drugs
Allogeneic Adoptive Immune Therapy
03
Conditions
acquired immunodeficiency syndrome (AIDS)
Beyond the preview
Go deeper on NCT04098770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04098770.